Canaccord Genuity Group Inc. (TSX:CF) Acquires Carbon Reduction Capital, LLC

TORONTO, ON — January 14, 2026 — Leads & Copy —

Canaccord Genuity Group Inc. has acquired Carbon Reduction Capital, LLC (CRC-IB) through its U.S. capital markets business. CRC-IB is known for providing M&A, project finance, and capital raising services in the U.S. renewable energy sector. They have experience in wind, solar, storage, carbon capture, and energy transition segments, having executed approximately 415 transactions totaling around US$91 billion since inception.

Jeff Barlow, CEO of Canaccord Genuity LLC (U.S.), stated that the acquisition reinforces the company’s focus on advisory and capital raising in high-growth sectors and accelerates sustainability ambitions by leveraging sector expertise. Conor McKenna, Partner and Senior Managing Director of CRC-IB, noted the acquisition enhances their ability to serve clients through an independent structure with international reach.

Following the acquisition, CRC-IB partners Conor McKenna, Nick Knapp, Britta von Oesen, and Gary Durden will become Co-Heads of Canaccord Genuity’s newly formed Energy Transformation group within its U.S. Sustainability – Energy and Industrial Transformation investment banking platform. The team will provide M&A, project finance, capital raising, and strategic advisory services to public and private companies and financial sponsors across the renewable energy, commercial, and industrial sectors.

Solomon Partners and Keefe, Bruyette & Woods acted as financial advisors to CRC-IB, with Willkie Farr & Gallagher as counsel. Debevoise & Plimpton LLP served as legal advisors to Canaccord Genuity.

Canaccord Genuity Group Inc., established in 1950, operates in wealth management and capital markets. Its international capital markets division operates in North America, UK & Europe, Asia, and Australia.

Contact:
Canaccord Genuity Group Inc.

Source: Canaccord Genuity Group Inc.

×

Welcome!

Biotech Reporter is the source most up-to-date real-time, direct-from-source News Tips and Story Leads.

By Subscribing you will receive Daily Biotech Update each day at 9:30 am ET (Market Open) in your inbox and you can unsubscribe any time.